| A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy X Du, F Tang, M Liu, J Su, Y Zhang, W Wu, M Devenport, CA Lazarski, ... Cell research 28 (4), 416-432, 2018 | 234 | 2018 |
| Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice X Du, M Liu, J Su, P Zhang, F Tang, P Ye, M Devenport, X Wang, Y Zhang, ... Cell research 28 (4), 433-447, 2018 | 108 | 2018 |
| An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose-and amino acid-deprivation P Ye, Y Liu, C Chen, F Tang, Q Wu, X Wang, CG Liu, X Liu, R Liu, Y Liu, ... Molecular cell 57 (4), 708-720, 2015 | 99 | 2015 |
| Intracellular CD24 disrupts the ARF–NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation L Wang, R Liu, P Ye, C Wong, GY Chen, P Zhou, K Sakabe, X Zheng, ... Nature communications 6 (1), 5909, 2015 | 58 | 2015 |
| DEXH-Box protein DHX30 is required for optimal function of the zinc-finger antiviral protein P Ye, S Liu, Y Zhu, G Chen, G Gao Protein & cell 1, 956-964, 2010 | 52 | 2010 |
| Siglec genes confer resistance to systemic lupus erythematosus in humans and mice R Flores, P Zhang, W Wu, X Wang, P Ye, P Zheng, Y Liu Cellular & Molecular Immunology 16 (2), 154-164, 2019 | 25 | 2019 |
| CD24–p53 axis suppresses diethylnitrosamine-induced hepatocellular carcinogenesis by sustaining intrahepatic macrophages D Li, M Hu, Y Liu, P Ye, P Du, CS Li, L Cheng, P Liu, J Jiang, L Su, ... Cell discovery 4 (1), 6, 2018 | 15 | 2018 |
| A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice F Tang, P Zhang, P Ye, CA Lazarski, Q Wu, IL Bergin, TP Bender, MN Hall, ... Elife 6, e32497, 2017 | 4 | 2017 |
| The development and functions of CD4+ T cells expressing a transgenic TCR specific for an MHC-I-restricted tumor antigenic epitope X Han, P Ye, L Luo, L Zheng, Y Liu, L Chen, S Wang Cellular & molecular immunology 8 (4), 333-340, 2011 | 2 | 2011 |
| Anti-cd24 compositions and uses thereof Y Liu, P Zheng, R Flores, HY Chou, Z Xue, P Ye, M Devenport US Patent App. 17/055,248, 2021 | 1 | 2021 |
| composições anti-cd24 e usos das mesmas Y Liu, P Zheng, R Flores, HY Chou, Z Xue, P Ye, M DEVENPORT | | 2021 |
| IMLEC: A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 F Tang, P Zhang, P Ye, CA Lazarski, Q Wu, IL Bergin, TP Bender, MN Hall, ... Cancer Research 78 (13_Supplement), 702-702, 2018 | | 2018 |
| Cd24 Defects Recapitulates Features of Aging Hematopoiesis P Zheng, Y Zhang, P Ye, W Wu, C Chen, Y Liu Biology of Blood and Marrow Transplantation 24 (3), S477-S478, 2018 | | 2018 |
| Expression and Purification of Glutathione S-Transferase Y Dan, Y Peiying, W Jin, L Yongping, M Huiwen Amino Acids and Biotic Resources 26 (3), 33-37, 2004 | | 2004 |
| Author response: A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice F Tang, P Zhang, P Ye, CA Lazarski, Q Wu, IL Bergin, TP Bender, MN Hall, ... | | |
